[HTML][HTML] Inflammation as a central mechanism in Alzheimer's disease

JW Kinney, SM Bemiller, AS Murtishaw… - Alzheimer's & Dementia …, 2018 - Elsevier
Alzheimer's disease (AD) is a progressive neurodegenerative disorder that is characterized
by cognitive decline and the presence of two core pathologies, amyloid β plaques and …

[HTML][HTML] Neuroinflammation in Huntington's disease: a starring role for astrocyte and microglia

J Saba, FL Couselo, J Bruno, L Carniglia… - Current …, 2022 - ncbi.nlm.nih.gov
Huntington's disease (HD) is a neurodegenerative genetic disorder caused by a CAG repeat
expansion in the huntingtin gene. HD causes motor, cognitive, and behavioral dysfunction …

Inflammation in Huntington's disease: A few new twists on an old tale

PAC Valadão, KBS Santos, THF e Vieira… - Journal of …, 2020 - Elsevier
Huntington's disease (HD) is a neurodegenerative disease characterized by prominent loss
of neurons in the striatum and cortex. Traditionally research in HD has focused on brain …

The microbiota–gut–brain axis in Huntington's disease: pathogenic mechanisms and therapeutic targets

MN Ekwudo, C Gubert, AJ Hannan - The FEBS Journal, 2024 - Wiley Online Library
Huntington's disease (HD) is a currently incurable neurogenerative disorder and is typically
characterized by progressive movement disorder (including chorea), cognitive deficits …

Circulating levels of inflammatory biomarkers in Huntington's disease: A systematic review and meta-analysis

AS Khaboushan, A Moeinafshar, MH Ersi… - Journal of …, 2023 - Elsevier
Background Huntington's disease (HD) is an autosomal dominant disease caused by an
abnormally high number of CAG repeats at the huntingtin-encoding gene, HTT. This genetic …

[HTML][HTML] Myelin breakdown in human Huntington's disease: Multi-modal evidence from diffusion MRI and quantitative magnetization transfer

J Bourbon-Teles, S Bells, DK Jones, E Coulthard… - Neuroscience, 2019 - Elsevier
Huntington's disease (HD) leads to white matter (WM) degeneration that may be due to an
early breakdown in axon myelination but in vivo imaging correlates of demyelination remain …

Fluid and imaging biomarkers for Huntington's disease

P Zeun, RI Scahill, SJ Tabrizi, EJ Wild - Molecular and Cellular …, 2019 - Elsevier
Huntington's disease is a chronic progressive neurodegenerative condition for which there
is no disease-modifying treatment. The known genetic cause of Huntington's disease makes …

Translating cell therapies for neurodegenerative diseases: Huntington's disease as a model disorder

AE Rosser, ME Busse, WP Gray, RA Badin, AL Perrier… - Brain, 2022 - academic.oup.com
There has been substantial progress in the development of regenerative medicine strategies
for CNS disorders over the last decade, with progression to early clinical studies for some …

Selected CSF biomarkers indicate no evidence of early neuroinflammation in Huntington disease

T Vinther-Jensen, L Börnsen… - Neurology …, 2016 - AAN Enterprises
Objective: To investigate CSF biomarkers of neuroinflammation and neurodegeneration in
Huntington disease (HD) gene-expansion carriers compared to controls and to investigate …

The updated development of blood-based biomarkers for Huntington's disease

S Zhang, Y Cheng, H Shang - Journal of Neurology, 2023 - Springer
Huntington's disease is a progressive neurodegenerative disease caused by mutation of the
huntingtin (HTT) gene. The identification of mutation carriers before symptom onset provides …